Herbalife, a premier health and wellness company, community and platform, has announced an agreement to acquire certain assets from Bioniq, a UK-based personalised supplements company focused on making health more accessible and actionable. The transaction advances Herbalife’s vision of becoming a technology-enabled, data-driven health and wellness platform.
“The future of health and wellness is becoming more personalised and informed by data,” said Herbalife Chief Executive Officer, Stephan Gratziani. “By combining Bioniq’s personalised supplement technology with Pro2col and the power of our global distributor network, we are expanding our ability to deliver personalised wellness at global scale.”
Bioniq develops personalised supplement formulas using its patented product personalisation engine, an individual’s health background and a proprietary database of biomarkers. Bioniq’s personalised supplement formulations are designed for a broad range of individuals, from everyday wellness consumers to elite athletes, including Cristiano Ronaldo.
Bioniq will complement Herbalife’s prior acquisitions of Pro2col and Link BioSciences by enabling Herbalife to offer a broader range of personalised nutritional supplements across multiple delivery formats. Combining Bioniq’s offering with Herbalife’s global manufacturing expertise will enable the company to expand personalised nutrition at scale and speed.
“I founded Bioniq in 2019 with a vision to help people optimise their wellbeing through a science-driven approach to nutrition that incorporates biomarker and lifestyle data,” said Vadim Fedotov, Founder and President of Bioniq. “I am excited to join Herbalife with its global distributor network and commitment to advancing wellness at scale.”
